MICB and breast carcinoma: Resveratrol has also been reported to elevate the major histocompatibility complex class I chain-related proteins A and B (MICA and MICB) expression in breast cancer cells by suppressing the c-Myc/miR-17 pathway (Figure 2), thus enhancing the susceptibility of breast cancer cells toward NK cells.